Eric A. Singer MD , MA, MS, FACS, FASCO (He/Him)

Summary

• I am a urologic surgeon with expertise in the management of genitourinary malignancies and a special interest in using robotic and minimally invasive surgery to treat cancers of the kidney, bladder, and prostate. My goal is to educate and empower my patients so that they can choose the best treatment option available, whether it is surgery, surveillance, radiation, systemic therapy, or a clinical trial. To that end, I work closely with my Medical Oncology and Radiation Oncology colleagues in order to offer patients an effective, individualized, and comprehensive cancer treatment plan that minimizes side effects and maximizes quality-of-life.
  
  I also serve as the Chief of the Division of Urologic Oncology here at the OSUCCC – James, as well as Director of the Urologic Oncology Fellowship Program and Co-Director of the Genitourinary Disease-Specific Research Group. 
  
  As a member of the Translational Therapeutics Program, my research is focused on developing new treatments for patients with genitourinary malignancies through clinical trials. I appreciate the camaraderie and the commitment to research shared by the exceptional team here at The James, which allows us to make progress on innovative techniques and provide the best care possible to our patients.
  
  In addition to my clinical work, I am a professor in the Department of Urology and in the Division of Bioethics at The Ohio State University College of Medicine. I am a Fellow of the American College of Surgeons (FACS) and Fellow of the American Society for Clinical Oncology (FASCO).